Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
BMJ Global Health|October 23, 2019
Quantifying changes in global health inequality: the Gini and Slope Inequality Indices applied to the Global Burden of Disease data, 1990-2017Fridolin Steinbeis, Dzintars Gotham, Peter von Philipsborn, et al.Journal of Virus Eradication|April 24, 2018
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?Andrew Hill, Sophie L Hughes, Dzintars Gotham, et al.BMJ Open|January 23, 2017
Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysisAndrew Hill, Christopher Redd, Dzintars Gotham, et al.Health Policy (Amsterdam, Netherlands)|January 6, 2021
Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United StatesDzintars Gotham, Lorenzo Moja, Maarten van der Heijden, et al.The Journal of Antimicrobial Chemotherapy|January 12, 2017
Estimated generic prices for novel treatments for drug-resistant tuberculosisDzintars Gotham, Joseph Fortunak, Anton Pozniak, et al.Plos One|December 7, 2023
Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021Ninell Kadyrova, Dzintars Gotham, Stanislav Kniazkov, et al.Journal of Virus Eradication|August 3, 2016
Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countriesAndrew Hill, Dzintars Gotham, Graham Cooke, et al.AIDS (London, England)|October 13, 2020
Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trialsVictoria Pilkington, Sophie L Hughes, Toby Pepperrell, et al.Health Research Policy and Systems|October 12, 2016
Global health equity in United Kingdom university research: a landscape of current policies and practicesDzintars Gotham, Jonathan Meldrum, Vaitehi Nageshwaran, et al.PLOS Global Public Health|April 23, 2025
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimensDzintars Gotham, Manuel Martin, Melissa J Barber, et al.Pageof 3